First Time Loading...

PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 0.105 AUD 5% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

39.8m
+7%
Assets
Growth Rates:
1 Year
+26%
3 Years
-37%
5 Years
+262%
7 Years
+512%
10 Years
+440%
9.9m
+5%
Liabilities
Growth Rates:
1 Year
+8%
3 Years
+172%
5 Years
+503%
7 Years
+839%
10 Years
+1 059%
29.9m
+8%
Equity
Growth Rates:
1 Year
+33%
3 Years
-50%
5 Years
+220%
7 Years
+449%
10 Years
+360%

Balance Sheet Decomposition
PYC Therapeutics Ltd

39.8m
Assets
9.9m
Liabilities
39.8m
Assets
9.9m
Liabilities
Current Assets 34.4m
Cash & Short-Term Investments 25.4m
Receivables 8.7m
Other Current Assets 314.4k
Non-Current Assets 5.4m
PP&E 1.2m
Intangibles 4.2m
Current Liabilities 8.6m
Accounts Payable 7.4m
Accrued Liabilities 897.8k
Other Current Liabilities 324.4k
Non-Current Liabilities 1.2m
Long-Term Debt 219.8k
Other Non-Current Liabilities 1m

Balance Sheet
PYC Therapeutics Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023
Assets
Cash & Cash Equivalents
4
1
7
10
3
6
7
18
29
16
Cash Equivalents
4
1
7
10
3
6
7
18
29
16
Short-Term Investments
0
0
0
0
0
0
18
33
0
0
Total Receivables
0
0
0
0
0
0
0
0
10
16
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
10
16
Other Current Assets
0
0
0
0
0
0
0
0
0
0
Total Current Assets
4
2
7
10
3
6
26
52
39
32
PP&E Net
0
0
0
0
0
0
1
1
2
1
PP&E Gross
0
0
0
0
0
0
1
1
2
1
Accumulated Depreciation
1
1
1
0
0
1
2
2
3
3
Intangible Assets
0
0
0
0
0
0
5
5
4
4
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
5
N/A
2
-60%
7
+307%
10
+42%
3
-67%
7
+96%
32
+371%
58
+84%
45
-22%
37
-18%
Liabilities
Accounts Payable
0
0
1
1
2
0
0
2
3
5
Accrued Liabilities
0
0
0
0
0
0
0
1
1
3
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
1
1
1
1
2
0
1
3
4
8
Long-Term Debt
0
0
0
0
0
0
1
1
1
0
Minority Interest
0
0
0
0
0
0
2
1
1
1
Other Liabilities
0
0
0
0
0
0
0
0
0
0
Total Liabilities
1
N/A
1
+2%
1
+74%
1
+4%
2
+19%
0
-77%
4
+794%
5
+36%
6
+23%
9
+57%
Equity
Common Stock
40
40
48
53
53
62
87
126
126
140
Retained Earnings
36
39
43
44
52
56
59
73
87
112
Total Equity
4
N/A
1
-74%
6
+506%
9
+52%
2
-81%
6
+282%
28
+344%
53
+90%
39
-26%
28
-29%
Total Liabilities & Equity
5
N/A
2
-60%
7
+307%
10
+42%
3
-67%
7
+96%
32
+371%
58
+84%
45
-22%
37
-18%
Shares Outstanding
Common Shares Outstanding
1 226
1 226
2 058
2 177
2 196
2 508
2 953
3 181
3 181
3 417

See Also

Summary
PYC intrinsic value, competitors valuation, and company profile.
DCF Valuation
PYC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PYC stock valuation using valuation multiples.
Wall Street Estimates
PYC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PYC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.